title: Hydration of surfactant-modified and PEGylated cationic cholesterol-based liposomes and corresponding lipoplexes by monitoring a fluorescent probe and the dielectric relaxation time.
abstract: For the optimization of plasmid DNA (pDNA)-cationic lipid complexes and lipoplex delivery, proper indexes of the physicochemical properties of lipoplexes are required. In general, the characteristics of lipoplexes are defined by particle size and zeta-potential at various mixing ratios of cationic liposomes and pDNA. In this study, we characterized the hydration level of surfactant-modified and PEGylated cationic cholesterol-based (OH-Chol) liposomes and their lipoplexes by monitoring both the fluorescent probe laurdan and the dielectric relaxation time. Fluorescence measurement using laurdan detected hydration of the headgroup of lipids in surfactant-modified liposomes and PEGylated DOTAP-liposomes, but hardly any fluorescence was detected in PEGylated OH-Chol-liposomes because the PEG layers may extend and cover the fluorescent maker. On the other hand, the measurement of dielectric relaxation time of water molecules revealed total hydration, including hydration of the PEG layer and the headgroup of cationic lipids. Furthermore, we found an inverse correlation between hydration level and cellular uptake of PEGylated lipoplexes (R=0.946). This finding indicated that the dielectric relaxation time of water molecules provides an important indicator of hydration of liposome and lipoplexes along with the fluorescence intensity of laurdan.
authors.affiliation: Institute of Medicinal Chemistry, Hoshi University, Ebara 2-4-41, Shinagawa-ku, Tokyo 142-8501, Japan. yoshie@hoshi.ac.jp
authors.forename: Yoshie
authors.initials: Y
authors.lastname: Maitani
authors.forename: Ayako
authors.initials: A
authors.lastname: Nakamura
authors.forename: Takumi
authors.initials: T
authors.lastname: Tanaka
authors.forename: Yukio
authors.initials: Y
authors.lastname: Aso
mesh_terms: D045744:Cell Line, Tumor; D002784:Cholesterol / Q000737:chemistry*; D004247:DNA / Q000008:administration & dosage; D016503:Drug Delivery Systems; D004563:Electrochemistry; D005079:Excipients / Q000737:chemistry*; D005434:Flow Cytometry; D005456:Fluorescent Dyes / Q000737:chemistry*; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D008081:Liposomes / Q000737:chemistry*; D008156:Luciferases / Q000235:genetics; D010957:Plasmids / Q000819:agonists; D011092:Polyethylene Glycols / Q000737:chemistry*; D013501:Surface-Active Agents / Q000737:chemistry*; D014162:Transfection
chemical_list: D005079:Excipients; D005456:Fluorescent Dyes; D008081:Liposomes; D013501:Surface-Active Agents; D011092:Polyethylene Glycols; D004247:DNA; D002784:Cholesterol; D008156:Luciferases